How many institutions held MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value in Q2 2020?

23 institutional investors reported MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value for Q2 2020. Use the holders table for investor-level position and value details.

Milestone Pharmaceuticals Inc. - Common Shares, no par value (MIST)

Q: What does CUSIP 59935V107 represent in this 13F holders report?

CUSIP 59935V107 is the security identifier for MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value used to aggregate holder disclosures.

CUSIP: 59935V107

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / Common Shares, no par value
Total 13F shares: 9,754,497
Total 13F value: $36,871,064
Share change: +511,499
SEC-reported price per share: $3.78
Number of holders: 23
Value change: +$2,941,736
Number of buys: 14
Number of sells: 6
Shares outstanding: 124,217,096

Security key

59935V107

Report period

Q2 2020

Institutions

Top holders

MIST full security history Ownership snapshot Full 13F holder table Milestone Pharmaceuticals Inc. SEC filings Milestone Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RTW INVESTMENTS, LP

Disclosed value leader

RTW INVESTMENTS, LP

Comparable rows

15/15

Latest evidence

31 Mar 2020

13F Lead comparable stake: 3.5% Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP leads the comparable SEC ownership view at 3.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.

Comparable ownership Top 5

RTW INVESTMENTS, LP 3.5%

Novo Holdings A/S 1.7%

Boxer Capital, LLC 0.89%

PRICE T ROWE ASSOCIATES INC /MD/ 0.47%

Invesco Ltd. 0.26%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RTW INVESTMENTS, LP	13F Company 13F	3.5%	$7,940,000 4,315,102 shares	—	31 Mar 2020
Novo Holdings A/S	13F Company 13F	1.7%	$3,828,000 2,080,585 shares	—	31 Mar 2020
Boxer Capital, LLC	13F Company 13F	0.89%	$2,028,000 1,102,194 shares	—	31 Mar 2020
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	0.47%	$1,076,000 584,615 shares	—	31 Mar 2020
Invesco Ltd.	13F Company 13F	0.26%	$589,000 320,377 shares	—	31 Mar 2020
Tekla Capital Management LLC	13F Company 13F	0.17%	$392,000 213,310 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

9,754,497

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q2 2020 value	Value change	Value Chg %